#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Eosinophilic granulomatosis with polyangiitis Cushing's syndrome Spinal cord injury Anaemia Ductal adenocarcinoma of pancreas KBG syndrome Cholangiosarcoma Hyperinsulinaemic hypoglycaemia Hidradenitis Juvenile psoriatic arthritis Rosai-Dorfman syndrome Heart disease congenital Multifocal motor neuropathy Thromboangiitis obliterans Antiphospholipid syndrome More trials…

    Learn about Rare Diseases

    Kearns-Sayre syndrome – Treatment Mucopolysaccharidosis – Trials in Disease Kearns-Sayre syndrome Hyperoxaluria – Treatment Mantle cell lymphoma – Treatment Phenylketonuria – Life with Disease Congenital nephrogenic diabetes insipidus – Treatment Haemophilia Short-bowel syndrome – Life with Disease Haemophilia A with anti factor VIII – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Metamizole Human Vaccinia Immunoglobulin PF-07868489 Anthoxanthum Odoratum Jnj-77242113 Oxygen Rivaroxaban Deferoxamine Mesilate Zofenopril Calcium Ttf-Ngr Apremilast Buserelin Acetate Magnesium Chloride Hexahydrate Petrelintide Methohexital Sodium Atacicept Ranitidine Hydrochloride Idecabtagene Vicleucel Tacrolimus Monohydrate Pravastatin Sodium More therapies…

    Learn about Your Condition

    Retinopathy of prematurity Measles Hand dermatitis Ejection fraction normal Milk allergy Procedural anxiety Hepatic angiosarcoma Intracranial calcification Osteosarcoma recurrent Rosai-Dorfman syndrome HER2 protein overexpression Haemolytic uraemic syndrome Mitral valve prolapse Immune-mediated enterocolitis Adenosquamous cell lung cancer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Estonia

  • Study on the Safety and Effectiveness of Diamyd and Colecalciferol for Adolescents and Adults with Recently Diagnosed Type 1 Diabetes

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Glutamate Decarboxylase 2, Human, Recombinant
    • Colecalciferol
    Czechia Estonia Germany Hungary The Netherlands Poland +2
  • Study on Human Normal Immunoglobulin to Prevent Early Infections in Patients with Newly Diagnosed Multiple Myeloma Not Eligible for Transplant

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Human Normal Immunoglobulin
    Denmark Estonia Norway
  • Study of Pembrolizumab with Chemotherapy for Patients with Resectable Stage II, IIIA, and IIIB Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Cisplatin
    • Gemcitabine
    • Pembrolizumab
    Belgium Estonia France Germany Ireland Italy +5
  • Study on LSTA1 and Temozolomide for Patients with Newly Diagnosed Glioblastoma Multiforme

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Glioblastoma multiforme
    Investigated Drugs:
    • Lsta1
    • Temozolomide
    Estonia Latvia Lithuania
  • Study Comparing Pembrolizumab Alone and with Sacituzumab Govitecan for Patients with Metastatic Non-Small Cell Lung Cancer with High PD-L1 Levels

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer metastatic
    Investigated Drugs:
    • Pembrolizumab
    Estonia Germany Greece Italy Latvia Lithuania +2
  • Study on the Effects of Upadacitinib in Adults with Moderate to Severe Systemic Lupus Erythematosus (SLE)

    Not recruiting

    3 1
    Investigated Drugs:
    • Upadacitinib
    Belgium Bulgaria Croatia Estonia France Germany +10
Previous Page
1 … 23 24 25 26 27 … 32
Next Page

Find Clinical Trials in Your Selected Region and City

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Pembrolizumab Cisplatin Dexamethasone Fluorouracil Oxaliplatin Risankizumab Durvalumab Hydrocortisone Prednisolone Prednisone Carboplatin Tocilizumab Mycophenolate Mofetil Cytarabine Venetoclax Etoposide Olaparib Upadacitinib Vincristine Sulfate Pneumococcal Polysaccharide Serotype 1 Inclisiran Pneumococcal Polysaccharide Serotype 3 Mitomycin Pneumococcal Polysaccharide Serotype 10A Apixaban Pneumococcal Polysaccharide Serotype 33F GSKVX000000025896 Rosuvastatin Pneumococcal Polysaccharide Serotype 11A Calcium Folinate Show more

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

Acromegaly Acute coronary syndrome Acute kidney injury Acute lymphocytic leukaemia Acute myeloid leukaemia Acute myocardial infarction Adenocarcinoma gastric Adenocarcinoma of colon Adrenogenital syndrome Age-related macular degeneration Arteriosclerosis Asthma Atrial fibrillation Axial spondyloarthritis Bladder cancer Cardiac failure Cardiovascular disorder Cerebrovascular accident prophylaxis Chronic graft versus host disease Chronic inflammatory demyelinating polyradiculoneuropathy Chronic kidney disease Chronic lymphocytic leukaemia Chronic obstructive pulmonary disease Chronic rhinosinusitis with nasal polyps Coagulation factor X level Colitis ulcerative Colorectal cancer metastatic Colorectal cancer stage IV Coronary artery disease Critical illness Crohn's disease Cytomegalovirus immunisation Dementia Alzheimer's type Dermatitis atopic Diabetic foot infection Diffuse large B-cell lymphoma Diffuse large B-cell lymphoma refractory Dyslipidaemia Emphysema Encephalopathy neonatal Endocrine ophthalmopathy Endometrial cancer Factor IX deficiency Factor VIII deficiency Focal segmental glomerulosclerosis Follicular lymphoma Gastric cancer Generalised anxiety disorder Genital herpes simplex Glioblastoma multiforme Hepatocellular carcinoma Herpes simplex Herpes zoster Hormone-refractory prostate cancer Hypercholesterolaemia Idiopathic pulmonary fibrosis IgA nephropathy Influenza Influenza immunisation Interstitial lung disease Lupus nephritis Macular oedema Major depression Mantle cell lymphoma Metapneumovirus infection Metastatic malignant melanoma Microsatellite instability cancer Multifocal motor neuropathy Multiple sclerosis Multiple sclerosis relapse Myelodysplastic syndrome Neonatal asphyxia Neoplasm Neoplasm malignant Neovascular age-related macular degeneration Nephropathy Non-small cell lung cancer Non-small cell lung cancer metastatic Non-small cell lung cancer stage II Non-small cell lung cancer stage III Non-small cell lung cancer stage IIIA Non-small cell lung cancer stage IIIB Obesity Oesophageal adenocarcinoma Oesophageal carcinoma Orthostatic hypotension Osteoarthritis Osteoporosis postmenopausal Overweight Paroxysmal nocturnal haemoglobinuria PD-L1 positive cancer Plasma cell myeloma Plasma cell myeloma refractory Pneumococcal immunisation Pneumonia Pneumonia respiratory syncytial viral Primary biliary cholangitis Primary progressive multiple sclerosis Progressive relapsing multiple sclerosis Prophylaxis of nausea and vomiting Prostate cancer Prostate cancer recurrent Psoriasis Psoriatic arthropathy Pyelonephritis acute Relapsing multiple sclerosis Relapsing-remitting multiple sclerosis Renal disorder Respiratory syncytial virus bronchiolitis Respiratory syncytial virus bronchitis Respiratory syncytial virus infection Retinal vein occlusion Rheumatoid arthritis Richter's syndrome Secondary progressive multiple sclerosis Short-bowel syndrome Sjogren's syndrome Small cell lung cancer Small cell lung cancer extensive stage Small cell lung cancer limited stage Systemic lupus erythematosus Systemic scleroderma Thrombosis prophylaxis Type 1 diabetes mellitus Urinary tract infection Varicella

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!